Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

Clinical trial NCT07324837 · RECRUITING

Trial details

NCT number: NCT07324837
Sponsor: Supergene, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke, Acute

Start date: 2026-06-09
Primary completion: 2028-11-01
Enrollment: 990

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.